Object. With the commercial availability of a variety of shunt systems, there is considerable controversy over the choice of the most appropriate shunt valve for each individual with hydrocephalus. Although the performance characteristics of all shunt systems are well documented in the laboratory setting, there is little description of the in vivo dynamics of intracranial pressure (ICP) after implantation of commonly used shunt systems in humans. The authors coupled telemonitoring devices to several different shunt systems to measure the performance characteristics of these valve systems with respect to intraventricular pressure (IVP) at increments of head elevation.
Shunt valves for CSF fall into several distinct categories, which include basic differential-pressure valves, those with an integral or inline antisiphoning device, 31 and valves that are designed to regulate by flow rather than by pressure differentiation. 8, 9 Although hydrocephalus in humans is presumably a multifactorial disease, there are no guidelines as to which specific shunt product might be more appropriate for hydrocephalus of a certain origin. Recent evaluations of various types of shunt valves in which the time from implantation to malfunction was assessed may even be interpreted as suggesting that there is no difference in appropriateness of shunt valves. 9 Recommendations of various shunts for specific types of hydrocephalus have generally been based on laboratory data rather than on the in vivo dynamics of shunt systems. 12, 28 Noninvasive extracranial monitors of CSF shunt pressure have been available for some time but have been used infrequently. 4, 7, 15, 17 A telemonitor based on an implanted radiofrequency circuit (TeleSensor) has been used in the past to measure ICP dynamics under a variety of conditions in patients with and without shunts in place. 5 We have adopted the use of the TeleSensor as a standard adjunct to the management of patients with hydrocephalus and implanted shunts. In this fashion, we have had the opportunity to couple the telemonitoring device to a large variety of commercially available shunts and have been able to assess their in vivo pressure dynamics while monitoring shunt function. This has allowed us to observe similarities and differences in the in vivo ICPs achieved using these shunts.
Clinical Material and Methods

Clinical Data
Twenty-five shunt systems were implanted in 22 patients (13 male, nine female) over a 3-year period. The median age of these patients at the time of shunt implantation or revision was 27.5 years (range 7-71 years). There were three patients with myelomeningocele-related hydrocephalus, two with NPH, and 17 with either posthemorrhagic hydrocephalus or hydrocephalus of unknown cause at the time of TeleSensor implantation. No patient was known to have noncommunicating hydrocephalus.
Each shunt system included a TeleSensor device in series proximal to the valve within the system's shunt components. All shunt systems were ventriculoperitoneal except two: a medium-pressure Radionics contour-flex valve and a Codman-Medos valve with a PS Medical siphon-control device, both of which were ventriculoatrial shunts. The distribution of valve systems was as follows: 1) differential-pressure systems: two PS Medical highpressure contour valves, one PS Medical medium-pressure contour valve, one Heyer-Schulte medium-pressure low-profile valve, one Hakim low-pressure valve, one Radionics low-pressure contour-flex valve, and five Radionics medium-pressure contour-flex valves; 2) nonsiphoning systems: two Delta 1.0 and two Delta 1.5 valves, one Equiflow low-pressure and one Equiflow medium-pressure valve, one PS Medical high-pressure contour valve with a PS Medical siphon-control device, one Radionics medium-pressure contour-flex valve with a Radionics siphon-limiting device, one Radionics low-pressure contour-flex valve with a Radionics siphon-limiting device, two Codman-Medos valves with a PS Medical siphoncontrol device; and 3) flow-controlled systems: four Cordis OSVs. 4 The group of patients without shunts (controls) consisted of three individuals with TeleSensors connected in a blunt-ended fashion to ventricular catheters. Two of these patients had undergone endoscopic fenestration of cysts (pineal region and lateral ventricular cysts) with subsequent catheter placement for hydrocephalus that did not develop. The third patient underwent repair of a frontal leptomeningeal cyst in the setting of ventriculomegaly; a catheter was placed to treat the expected hydrocephalus, which never developed. All three patients had been asymptomatic for at least 6 months after the catheter placement before their ICP values were used as unshunted control values.
Measurements of ICP
The ICP measurements were obtained as described 10, 18 by using the TeleSensor device. [4] [5] [6] [7] Angles of elevation of the head were estimated from a tilt table or from the anglemeasuring device found in the frames of hospital beds. Measurements were performed two to three times over 20 to 30 seconds at each postural elevation (0˚, 15˚, 30˚, 45˚, 60˚, 75˚, and 90˚). Our system did not include a negativepressure generator, as reported in Chapman, et al.; 5 therefore we were unable to assess the magnitude of negative pressures. Negative pressures were necessarily expressed as zero values. There were no differences greater than 1 cm H 2 O among multiple measurements performed at any head elevation; therefore, results were plotted using the mean value of these measurements ( Figs. 1-5 ). Intracranial pressures are expressed in centimeters of water, as calibrated on the telemonitoring system, measured at the site of the TeleSensor. Due to a hysteresis effect from head raising and lowering as reported previously, 5 ICP is expressed only for head-of-bed elevation. Results were plotted directly as pressure against degree of elevation of the head of the bed.
Statistical Analysis
For control patients without shunts and for each shunt system, a dynamic-pressure curve was obtained, as shown in Figs. 1 through 4. These values were subjected to multiple regression analyses to determine a best-fit regression coefficient. The regression coefficients were then grouped by shunt system type: differential-pressure, nonsiphoning, and flow-regulated valves, and control, and these groups were subjected to analysis of variance. Significance was determined using Fisher's post-hoc analysis at the 5% level. All statistical analyses were performed using the Statview 4.0 statistics package running on a Macintosh personal computer.
Sources of Equipment
The TeleSensor and the telemonitoring system (models ICP-M4 and ICP-M3) were purchased from Radionics, Burlington, MA, as were the low-and medium-pressure contour-flex valves, the Equiflow valves, and the siphonlimiting device. The high-and medium-pressure PS Med- 
Results
Dynamic ICP curves for the shunt systems examined, as well as controls, are shown in Figs. 1 through 4. We observed that in patients with raised ICP in whom differential-pressure valve systems were used (Fig. 2) all curves had crossed the zero intercept by 30˚ of head elevation. This was in contrast with the controls (Fig. 1) , as well as patients with nonsiphoning ( Fig. 3 ) and flow-dependent (Fig. 4) shunt systems. The nonsiphoning shunt systems generated dynamic-pressure curves that were very similar to those found in the controls, both in curve shape and in the zero intercept. The flow-dependent shunt systems were variable in curve shape and had similarities to both differential-valve systems and nonsiphoning systems.
Controls (three patients) were found to have a mean regression coefficient of r = Ϫ0.112 Ϯ 0.037 (mean Ϯ standard error of the mean). The 11 patients with differentialpressure valve systems had a mean regression coefficient of r = Ϫ0.321 Ϯ 0.061, which was significantly different from that of the controls (p Ͻ 0.049). In the 10 patients with nonsiphoning valve systems a mean regression coefficient of r = Ϫ0.158 Ϯ 0.027 was produced, which was also significantly different from that in the differential-valve systems (p Ͻ 0.0226). There was no difference between the nonsiphoning valve group and the control group. The four flow-regulated valve systems (r = Ϫ0.16 Ϯ 0.056) were not found to have a significantly different regression coefficient from the group with differential-pressure valves, those with the nonsiphoning systems, or controls. This may be a function of the small sample size or it may reflect the variability of the pressure dynamics in each of the flow-control valves (Fig. 4) .
Three valve systems were revised after initial pressures had been obtained. These revisions consisted of the addition of a nonsiphoning component to an existing differential-pressure (siphoning) valve system (PS Medical high-pressure contour valve with or without a PS Medical siphon-control device, Radionics medium-or low-pressure contour-flex valves with or without a Radionics siphon-limiting device.) The changes produced in these specific shunt systems are highlighted in Fig. 5 . Of note, the high-and medium-pressure valve systems appeared to have additional resistance added to the system, as well as changes in the zero intercept. The curves for the low-pressure system crossed the zero intercept at a relatively low head elevation, which did not allow observation of the curve changes, although the pressure in the supine position was elevated by the nonsiphoning component. These changes in the dynamic curve likely explain the effects of the nonsiphoning component on symptomatic low-pressure phenomena.
Within the three groupings of valve type, there appeared to be no consistent differences based on valve manufacturer, although the number of shunt products from each manufacturer was small. As noted, readings in all differential-pressure valves reached a zero intercept by 30˚ of head elevation, and values for all nonsiphoning valves appeared to have a much flatter curve than in differential-valve systems, regardless of manufacturer. Unfortunately, we were unable to examine the pressure curves in the negative-pressure range to assess the stringency of antisiphoning activity of each specific nonsiphoning valve system. However, these basic observations indicate that as far as delivery of a specific pressure dynamic, overall shunt design differences are much more important than variations in shunt construction among manufacturers.
Discussion
We have examined the in vivo pressure dynamics in 25 variations of CSF shunt systems by using an implanted
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In vivo ICP dynamics in CSF shunts (noninvasive) telemonitor. On dividing the shunt systems by design into groupings of differential-pressure valves, nonsiphoning valves, and flow-regulated valves, we found that the differential-pressure valves produced ICP pressure dynamics that were significantly different from both of the other groups, as well as controls. Our results are not surprising in that a different shunt valve design will likely result in differences in valve performance. However, the specifics of these differences, although theoretically discussed after in vitro examination, 8, 12, [26] [27] [28] [29] have never been examined or confirmed in a systematic in vivo study. Our novel observations may lead to a more careful selection of shunt products for individual patients.
Control Patients and Telemetric ICP Monitoring
The shapes of the dynamic ICP curves that were observed in the three controls (Fig. 1) were similar to those found previously in a telemetric study of variations in ICP with postural changes. 5 This observation confirms that the telemetric measurements of ICP are relatively constant, at least in curve shape, when compared among normal volunteers. Other studies based on telemetric measurements of dynamic ICP that were obtained using the Radionics TeleSensor have produced results that are consistent with predictions of pressure changes. We have previously found that successful ventriculocisternostomy for aqueductal stenosis will eventually produce a dynamic ICP curve 10 similar to that reported for normal volunteers by Chapman, et al. 5 A telemetric study of the pressure dynamics of ventriculopleural CSF shunting produced ICP curves that were reasonably explained by the predicted pressure phenomena of the pleural space. 18 As the literature describing in vivo ICP dynamics derived by telemetric monitors continues to expand, further confirmation of the utility of the device, as well as its usefulness as an investigational tool, should emerge.
Differential-Pressure Shunt Systems
The differential-pressure valve shunt systems produced dynamic ICP curves that were steep and that crossed the zero intercept at 30˚ of head elevation (Fig. 2) . This result was significantly different from the curves seen in controls. The most common functional complications of ventriculoperitoneal shunt placement are related to overdrainage phenomena: 20 subdural hematoma, slit ventricle syndrome, 24 low-pressure headache, and craniosynostosis. 16 Our data readily explain these phenomena by the fundamental difference in ICPs produced by the differential-pressure valve when compared with the control patients. Constant and abnormally low or negative pressure in the nonsupine position theoretically may affect bone growth and cerebral perfusion, and, in young children, brain development. This may explain why, although the overt symptoms of hydrocephalus (such as vomiting, bradycardia, or bulging fontanelle) disappear, in children who undergo shunt placement at birth, long-term deficits in cognition remain. 1, 3, 23 A detailed study of neurocognitive outcome based on shunt dynamics and ICP would be optimal to determine the best ICP dynamic for higher cortical neural development.
Interestingly, all differential shunt systems examined produced the same type of curve without regard to vendor or specifics of the valve design (for example, Hakim valve ruby ball/metal arm compared with PS Medical Silastic diaphragm). This observation supports the notion that shunt valve dynamics are nearly identical between vendors, although other attributes, such as durability, may be very different. A similar observation was made among the various nonsiphoning valve systems examined in this study.
Nonsiphoning Valve Shunt Systems
The dynamic intraventricular pressure curves observed in patients with nonsiphoning shunt systems (Fig. 3) were much closer in shape and zero intercept to the controls than what was observed in patients with differential valve shunts. This observation is predicted by the design of the system, which should not allow negative pressure (relative to atmospheric pressure) as the patient's head is elevated. Pressure in the supine position still appeared to be mostly controlled by the differential pressure portion of the valve system.
Several aspects of this type of pressure curve deserve discussion. The nonsiphoning valve appears to restore relatively normal ICP dynamics. This result is depicted most directly in Fig. 5 , which shows ICPs from the same patients before and after addition of a nonsiphoning component to the shunt system. Although only three patients are depicted, there is clearly more resistance in the nonsiphoning system, and the zero intercept is much higher in two of the patients. These observations lead us to conclude that the consequences of overshunting, such as headache, slit ventricle syndrome, and premature closure of the sutures, will be reduced by the use of nonsiphoning valves.
There are some situations such as the NPH syndrome that may require subnormal ICPs, 25 in which restoring normal pressures may not affect the disease. Normal-pressure hydrocephalus, analogous to low-pressure hydrocephalus, 30 may require subnormal ICPs for effective treatment. Although low-pressure hydrocephalus may require the negative pressures associated with ventriculopleural shunting, 18 it would seem that NPH may not always be adequately treated by a nonsiphoning system shunting to the peritoneum. Previous bench test observations have prompted the prediction that Delta valves may not adequately treat NPH caused by undershunting. 12 This conclusion was based on possible technical failure of the antisiphoning component rather than pressure mismatch.
Because newborns tend to have lower ICPs than children or adults, 11 brain injury from hydrocephalus in a newborn may require decreased ICP for brain recovery and development. This group may benefit more from a differential-pressure system than from the relatively normal pressures predicted according to observations of nonsiphoning valves; previous observations of differentialpressure valve systems have indeed found elevations in cerebral perfusion. 13 
Flow-Regulated Valves
Our study of flow-regulated valves consisted of a group of only four implanted OSVs. 14 We have not yet encountered a Diamond valve 19 that has been coupled to a TeleSensor device. Although it is difficult to generalize from such a small sample size, the ICP curves generated in patients with OSVs appeared to conform to an intermediate area between nonsiphoning shunt system curves and those from the differential-pressure valve systems. This would be predicted from the tendency of the valve not to allow very negative pressures, due to the increased impedance to flow with relative differential pressure from head to belly, yet no set differential opening and closing pressure. The dynamics of the shunt in the negative pressure range cannot be addressed in our study. However, they may be very negative in that the OSV has been linked to a high rate of subdural hematoma in patients with NPH, when compared with differential-pressure valve systems. 32 
Comparison Among Valve Systems
The results of the Pediatric Valve Design Trial 9 have led to predictions of a similar rate of malfunction between differential-pressure valves, nonsiphoning valves, and OSVs. Because the majority of malfunctions are caused by ventricular catheter occlusion and not valve malfunction, this is not unexpected. However, our study clearly shows that shunt systems of fundamentally different design produce significantly different dynamic ICPs in vivo (Figs. 2-4) . The significance of this finding is important for choosing a shunt system in the context of the multifactorial origins of hydrocephalus. It may be that certain types of hydrocephalus (for example, communicating compared with noncommunicating) or hydrocephalus associated with certain types of brain injury (for example, prenatal infarct) may respond better to a specific pressure dynamic. This dynamic may not change the rate of shunt malfunction but may only be reflected by improved symptoms or better performance on neurocognitive testing. The introduction of a programmable differential-pressure valve 2, 21, 22 will allow fine-tuning of ICP in the patient with hydrocephalus who undergoes shunt placement. We hope that knowledge of the in vivo ICP dynamics of a variety of shunt systems, coupled with detailed studies linking pressure dynamics and outcome, will allow implantation of the most effective shunt system possible in each individual with hydrocephalus.
